🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Mundipharma Pharmaceuticals Limited — Licensed Medicines

47 medicines held by Mundipharma Pharmaceuticals Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 47 products held by Mundipharma Pharmaceuticals Limited
MedicineActive substanceLicence holderStatus
Adizem-SR 120 mg Prolonged Release Capsules
PA1688/001/002
 Diltiazem hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Adizem-SR 180 mg Prolonged Release Capsules
PA1688/001/003
 Diltiazem hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Adizem-SR 90 mg Prolonged Release Capsules
PA1688/001/001
 Diltiazem hydrochloride Mundipharma Pharmaceuticals Limited Marketed
ADIZEM-XL 120mg prolonged release capsules
PA1688/001/004
 Diltiazem hydrochloride Mundipharma Pharmaceuticals Limited Marketed
ADIZEM-XL 180mg prolonged release capsules
PA1688/001/005
 Diltiazem hydrochloride Mundipharma Pharmaceuticals Limited Marketed
ADIZEM-XL 240 mg prolonged release capsules
PA1688/001/006
 Diltiazem hydrochloride Mundipharma Pharmaceuticals Limited Marketed
ADIZEM-XL 300 mg prolonged release capsules
PA1688/001/007
 Diltiazem hydrochloride Mundipharma Pharmaceuticals Limited Marketed
BuTrans 10 micrograms/hour transdermal patch
PA1688/002/002
 Buprenorphine Mundipharma Pharmaceuticals Limited Marketed
BuTrans 15 microgram/hour transdermal patch
PA1688/002/004
 Buprenorphine Mundipharma Pharmaceuticals Limited Marketed
BuTrans 20 micrograms/hour transdermal patch
PA1688/002/003
 Buprenorphine Mundipharma Pharmaceuticals Limited Marketed
BuTrans 5 micrograms/hour transdermal patch
PA1688/002/001
 Buprenorphine Mundipharma Pharmaceuticals Limited Marketed
Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension
PA1688/013/002
 Fluticasone propionate, Formoterol fumarate dihydrate Mundipharma Pharmaceuticals Limited Marketed
Flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension
PA1688/013/003
 Fluticasone propionate, Formoterol fumarate dihydrate Mundipharma Pharmaceuticals Limited Marketed
Flutiform 50 microgram/5 microgram per metered dose pressurised inhalation, suspension
PA1688/013/001
 Fluticasone propionate, Formoterol fumarate dihydrate Mundipharma Pharmaceuticals Limited Marketed
MST Continus 10 mg Prolonged-release tablets
PA1688/004/002
 Morphine sulfate Mundipharma Pharmaceuticals Limited Marketed
MST Continus 100mg Prolonged-release tablets
PA1688/004/006
 Morphine sulfate Mundipharma Pharmaceuticals Limited Marketed
MST Continus 15 mg Prolonged-release tablets
PA1688/004/003
 Morphine sulfate Mundipharma Pharmaceuticals Limited Marketed
MST Continus 30 mg Prolonged-release tablets
PA1688/004/004
 Morphine sulfate Mundipharma Pharmaceuticals Limited Marketed
MST Continus 5 mg prolonged-release tablets
PA1688/004/001
 Morphine sulfate Mundipharma Pharmaceuticals Limited Marketed
OxyContin 10 mg prolonged release tablets
PA1688/005/002
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 20 mg prolonged release tablets
PA1688/005/003
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 40 mg prolonged release tablets
PA1688/005/004
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 5 mg prolonged release tablets
PA1688/005/001
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 80 mg prolonged release tablets
PA1688/005/005
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Not marketed
OxyNorm 10 mg hard capsules
PA1688/006/005
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 10 mg/ml, solution for injection or infusion
PA1688/006/001
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 20 mg hard capsules
PA1688/006/006
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 5 mg hard capsules
PA1688/006/004
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 50 mg/ml, solution for injection or infusion
PA1688/006/010
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm concentrate 10 mg/ml oral solution
PA1688/006/003
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm Dispersa 10 mg Orodispersible Tablets
PA1688/006/008
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm Dispersa 20 mg orodispersible tablets
PA1688/006/009
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm Dispersa 5 mg Orodispersible Tablets
PA1688/006/007
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm liquid 1 mg/ml oral solution
PA1688/006/002
 OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
Palladone 1.3 mg hard capsules
PA1688/007/001
 Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Palladone 2.6 mg hard capsules
PA1688/007/002
 Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Not marketed
Palladone SR 2 mg prolonged release hard capsules
PA1688/007/007
 Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Palladone SR 4 mg prolonged release hard capsules
PA1688/007/008
 Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Palladone SR 8 mg prolonged release hard capsules,
PA1688/007/009
 Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Sevredol 10mg Film-Coated Tablets
PA1688/009/001
 Morphine sulfate Mundipharma Pharmaceuticals Limited Marketed
Sevredol 20 mg Film-Coated Tablets
PA1688/009/002
 Morphine sulfate Mundipharma Pharmaceuticals Limited Marketed
Targin 10mg/5mg prolonged-release tablets
PA1688/010/002
 OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
Targin 15 mg/7.5 mg prolonged-release tablets
PA1688/010/006
 OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
Targin 20mg/10mg prolonged-release tablets
PA1688/010/003
 OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
Targin 30 mg/15 mg prolonged-release tablets
PA1688/010/007
 OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
Targin 40 mg/20 mg prolonged-release tablets
PA1688/010/004
 OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
Targin 5 mg/2.5 mg prolonged-release tablets
PA1688/010/001
 OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.